Virtual | Virtual
Event Title
April 25, 2023: Conversations on Cancer: “Beginning the Rare Cancer Journey: Charting the Best Path to an Accurate Diagnosis”
April 25, 2023
- Date:
- April 25, 2023
- Time:
- 2:00 PM - 3:00 PM ET
Twitter: #ConversationsOnCancer
Background:
The FDA Oncology Center of Excellence (OCE) is excited to present a Conversations on Cancer titled “Beginning the rare cancer journey: charting the best path to an accurate diagnosis”. Join this 1-hour informal panel discussion featuring perspectives from patients with rare cancers and researchers and clinicians in the field. This public panel discussion is designed to bring greater awareness to the challenges to receiving the correct diagnosis experienced by some patients with rare cancers, and highlight opportunities and strategies to address these challenges in the era of personalized medicine.
Important issues that will be covered include:
- Patient, clinician, and pathologist perspectives on the difficulties associated with diagnosing some rare cancers
- Patient perspectives on the impact of delays in their rare cancer diagnosis
- Importance of timely access to appropriate diagnostic testing
- Barriers to correct diagnosis of rare cancers and ways to help overcome these barriers
Webcast Information:
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.
FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer
Contact:
For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov